Non-Markovian Population Dynamics: Does it Help to Optimize the Chemotherapeutic Strategy?
暂无分享,去创建一个
Majid Fallahi | Dmitry A. Kuznetsov | Sergey A. Roumiantsev | Nima Amirshahi | Andrey V. Makarov | Karina S. Kardashova
[1] Toru Ishibashi,et al. Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients. , 2003, British journal of clinical pharmacology.
[2] Donald J. Birkett,et al. Pharmacokinetics Made Easy , 1999 .
[3] K. Naidoo,et al. Modelling molecular structure and reactivity in biological systems , 2006 .
[4] K. Chisholm,et al. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells , 2004, Anti-cancer drugs.
[5] J. Soria,et al. Molecular targeting: targeting angiogenesis in solid tumors. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] Pierre Marquet,et al. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs , 2002, Fundamental & clinical pharmacology.
[7] H. Penefsky,et al. Immediate effects of anticancer drugs on mitochondrial oxygen consumption. , 2003, Biochemical pharmacology.
[8] J. Gautier. Drug Safety Evaluation , 2017, Methods in Molecular Biology.
[9] S. Rezayat,et al. New porphyrin adduct of fullerene-C60 : A promising nanotool for medicinal use in the heart muscle hypoxia cases , 2008 .
[10] A. Nadal,et al. Molecular biology of laryngeal squamous cell carcinoma , 2002, Virchows Archiv.